OR WAIT null SECS
Mike Hennessy Jr. is the President and CEO of MJH Life Sciences.
March 02, 2024
While Catalent’s acquisition is definitely about making drugs, it’s also very much about making money.
February 02, 2024
Given its positioning at each new year’s commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed.
January 02, 2024
GSI shortages result from how hospitals buy GSI drugs, and the underinvestment in manufacturing operations that follow.
December 02, 2023
Pharmaceuticals are entering a transition into a far more complex era of patient therapies, and patient segmentation.
November 02, 2023
Industry investments indicate increasing trust in the newest modalities, including mRNA approaches.
September 28, 2023
It has been a long wait, but for Alzheimer’s at least, this is the beginning of renewed hope.